Pharmacology jobs in United Kingdom

Social network you want to login/join with:

col-narrow-left

Tranent, United Kingdom

Other

-

Yes

col-narrow-right

0ad64091fe82

2

15.05.2025

29.06.2025

col-wide

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

At our world class facility in Elphinstone, Tranent (close to Edinburgh),our Administration & Reporting Department currently has an exciting career opportunity for an Assistant Sample Coordinator on a 12 month fixed term contract.

Due to our continued growth and success, we can offer rewarding opportunities in a research environment. Working as an Assistant Sample Coordinator, you’ll join a team which provides support to study management in the co-ordination and reporting of their studies.

Key Responsibilities:

• Prepare labels and apply to appropriate sample containers in preparation for scheduled sampling
• Preparing chain of custody in order to collect and transfer samples
• Preparing detailed electronic sample inventories according to Sponsor specific requirements
• Ordering packaging materials including boxes and dry ice
• Maintaining calendar of tasks according to protocol requirements

Applicants should have:

• English and Mathematics Standard Grades
• Proven experience of working within given timescales with a proactive working style
• Strong organizational skills with an eye for detail
• Experience in Microsoft Word
• Good written communication and people skills

The salary is £24,638.06 per annum.

The closing date is Monday, 26 May 2025.

About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 350patents and 80preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increasedto $2.62billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.